Literature DB >> 30561326

Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation.

Lucy LeBlanc1,2, Bum-Kyu Lee1,2, Andy C Yu1, Mijeong Kim1,2, Aparna V Kambhampati1, Shannon M Dupont1, Davide Seruggia3,4,5, Byoung U Ryu1, Stuart H Orkin3,6,5,4, Jonghwan Kim1,2.   

Abstract

Approximately, 30% of embryonic stem cells (ESCs) die after exiting self-renewal, but regulators of this process are not well known. Yap1 is a Hippo pathway transcriptional effector that plays numerous roles in development and cancer. However, its functions in ESC differentiation remain poorly characterized. We first reveal that ESCs lacking Yap1 experience massive cell death upon the exit from self-renewal. We subsequently show that Yap1 contextually protects differentiating, but not self-renewing, ESC from hyperactivation of the apoptotic cascade. Mechanistically, Yap1 strongly activates anti-apoptotic genes via cis-regulatory elements while mildly suppressing pro-apoptotic genes, which moderates the level of mitochondrial priming that occurs during differentiation. Individually modulating the expression of single apoptosis-related genes targeted by Yap1 is sufficient to augment or hinder survival during differentiation. Our demonstration of the context-dependent pro-survival functions of Yap1 during ESC differentiation contributes to our understanding of the balance between survival and death during cell fate changes.
© 2018, LeBlanc et al.

Entities:  

Keywords:  Yap1; apoptosis; differentiation; embryonic stem cells; mouse; regenerative medicine; stem cells

Mesh:

Substances:

Year:  2018        PMID: 30561326      PMCID: PMC6307859          DOI: 10.7554/eLife.40167

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  49 in total

Review 1.  Apoptosis in development.

Authors:  P Meier; A Finch; G Evan
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

2.  Scythe cleavage during Fas (APO-1)-and staurosporine-mediated apoptosis.

Authors:  Giulio Preta; Bengt Fadeel
Journal:  FEBS Lett       Date:  2012-01-26       Impact factor: 4.124

3.  The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.

Authors:  Luping Lin; Amit J Sabnis; Elton Chan; Victor Olivas; Lindsay Cade; Evangelos Pazarentzos; Saurabh Asthana; Dana Neel; Jenny Jiacheng Yan; Xinyuan Lu; Luu Pham; Mingxue M Wang; Niki Karachaliou; Maria Gonzalez Cao; Jose Luis Manzano; Jose Luis Ramirez; Jose Miguel Sanchez Torres; Fiamma Buttitta; Charles M Rudin; Eric A Collisson; Alain Algazi; Eric Robinson; Iman Osman; Eva Muñoz-Couselo; Javier Cortes; Dennie T Frederick; Zachary A Cooper; Martin McMahon; Antonio Marchetti; Rafael Rosell; Keith T Flaherty; Jennifer A Wargo; Trever G Bivona
Journal:  Nat Genet       Date:  2015-02-09       Impact factor: 38.330

Review 4.  Apoptosis in the development of the immune system.

Authors:  J T Opferman
Journal:  Cell Death Differ       Date:  2007-06-15       Impact factor: 15.828

5.  Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.

Authors:  Minchul Kim; Taekhoon Kim; Randy L Johnson; Dae-Sik Lim
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

6.  Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition.

Authors:  Maren Diepenbruck; Lorenz Waldmeier; Robert Ivanek; Philipp Berninger; Phil Arnold; Erik van Nimwegen; Gerhard Christofori
Journal:  J Cell Sci       Date:  2014-02-19       Impact factor: 5.285

7.  The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.

Authors:  Shumei Song; Soichiro Honjo; Jiankang Jin; Shih-Shin Chang; Ailing W Scott; Qiongrong Chen; Neda Kalhor; Arlene M Correa; Wayne L Hofstetter; Constance T Albarracin; Tsung-Teh Wu; Randy L Johnson; Mien-Chie Hung; Jaffer A Ajani
Journal:  Clin Cancer Res       Date:  2015-03-04       Impact factor: 12.531

8.  Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms.

Authors:  C A Belmokhtar; J Hillion; E Ségal-Bendirdjian
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

9.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

10.  Effect of YAP1 silencing on esophageal cancer.

Authors:  Jia Zhao; Xiangnan Li; Yang Yang; Dengyan Zhu; Chunyang Zhang; Donglei Liu; Kai Wu; Song Zhao
Journal:  Onco Targets Ther       Date:  2016-05-26       Impact factor: 4.147

View more
  10 in total

1.  Yap1 safeguards mouse embryonic stem cells from excessive apoptosis during differentiation.

Authors:  Lucy LeBlanc; Bum-Kyu Lee; Andy C Yu; Mijeong Kim; Aparna V Kambhampati; Shannon M Dupont; Davide Seruggia; Byoung U Ryu; Stuart H Orkin; Jonghwan Kim
Journal:  Elife       Date:  2018-12-18       Impact factor: 8.140

Review 2.  Context-dependent roles of YAP/TAZ in stem cell fates and cancer.

Authors:  Lucy LeBlanc; Nereida Ramirez; Jonghwan Kim
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 3.  YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.

Authors:  Frank Szulzewsky; Eric C Holland; Valeri Vasioukhin
Journal:  Dev Biol       Date:  2021-01-08       Impact factor: 3.148

4.  Effects of Spaceflight and Simulated Microgravity on YAP1 Expression in Cardiovascular Progenitors: Implications for Cell-Based Repair.

Authors:  Victor Camberos; Jonathan Baio; Leonard Bailey; Nahidh Hasaniya; Larry V Lopez; Mary Kearns-Jonker
Journal:  Int J Mol Sci       Date:  2019-06-04       Impact factor: 5.923

Review 5.  Cell death in head and neck cancer pathogenesis and treatment.

Authors:  Martina Raudenská; Jan Balvan; Michal Masařík
Journal:  Cell Death Dis       Date:  2021-02-18       Impact factor: 8.469

Review 6.  Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer.

Authors:  Seung Wan Son; Mun Gyu Song; Ba Da Yun; Jong Kook Park
Journal:  Biomedicines       Date:  2021-03-07

7.  Xeno- and Feeder-Free Differentiation of Human iPSCs to Trabecular Meshwork-Like Cells by Recombinant Cytokines.

Authors:  Wenyan Wang; Yongzhen Miao; Shangru Sui; Yanan Wang; Shen Wu; Qilong Cao; Haoyun Duan; Xia Qi; Qingjun Zhou; Xiaojing Pan; Jingxue Zhang; Xuehong Chen; Yantao Han; Ningli Wang; Markus H Kuehn; Wei Zhu
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

Review 8.  Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation.

Authors:  Juan Luo; Peng Li
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

9.  Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies.

Authors:  Youjun Wu; Tammy Chang; Yan Long; He Huang; Fouad Kandeel; Jiing-Kuan Yee
Journal:  iScience       Date:  2019-11-25

10.  YAP and TAZ protect against white adipocyte cell death during obesity.

Authors:  Lei Wang; ShengPeng Wang; Yue Shi; Rui Li; Stefan Günther; Yu Ting Ong; Michael Potente; Zuyi Yuan; Enqi Liu; Stefan Offermanns
Journal:  Nat Commun       Date:  2020-10-28       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.